The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2025

Filed:

Jul. 01, 2022
Applicants:

Op-t Llc, Aurora, CO (US);

The Regents of the University of Colorado, a Body Corporate, Denver, CO (US);

Inventors:

David Hal Wagner, Jr., Denver, CO (US);

Martin Glenn Yussman, Denver, CO (US);

Charles W. Henry, Denver, CO (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1793 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61P 3/10 (2018.01);
Abstract

Bioactive peptides and methods for their use for preventing, treating, and/or reducing the incidence and/or symptoms of an autoimmune disease or disorder that may result from chronic inflammation, damage to β-cells of the pancreas, and other conditions that are implicated by the CD40-CD154 dyad. In particular, small peptides that are capable of interacting with CD40, thereby interfering with the ability of CD40 to interact with CD154, which impacts inflammation, autoimmunity, and disease progression. The use of such peptides in reducing diabetes mellitus, and in particular, the autoimmune inflammatory response that may be a driving factor thereof. Methods and materials for preventing and modulating diabetes mellitus and autoimmune diseases especially in dogs, cats, and horses.


Find Patent Forward Citations

Loading…